CAD 0.26
(0.0%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 527.68 Thousand CAD | -13.28% |
2022 | 608.46 Thousand CAD | -54.46% |
2021 | 1.33 Million CAD | -10.38% |
2020 | 1.49 Million CAD | 28.13% |
2019 | 1.16 Million CAD | 6.58% |
2018 | 1.09 Million CAD | 165.81% |
2017 | 410.7 Thousand CAD | -30.64% |
2016 | 592.17 Thousand CAD | -73.21% |
2015 | 2.21 Million CAD | 20.7% |
2014 | 1.83 Million CAD | 89.36% |
2013 | 967.12 Thousand CAD | 0.0% |
2012 | - CAD | 0.0% |
2011 | - CAD | 0.0% |
2010 | - CAD | 0.0% |
2009 | - CAD | 0.0% |
2008 | - CAD | 0.0% |
2007 | - CAD | 0.0% |
2006 | - CAD | 0.0% |
2005 | - CAD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q3 | 587.18 Thousand CAD | 3.63% |
2024 Q2 | 566.63 Thousand CAD | 3.63% |
2024 Q1 | 546.81 Thousand CAD | 3.63% |
2023 Q4 | 527.68 Thousand CAD | -22.03% |
2023 Q3 | 676.81 Thousand CAD | 3.6% |
2023 FY | 527.68 Thousand CAD | -13.28% |
2023 Q2 | 653.28 Thousand CAD | 3.61% |
2023 Q1 | 630.5 Thousand CAD | 3.62% |
2022 Q1 | 726.16 Thousand CAD | -45.65% |
2022 FY | 608.46 Thousand CAD | -54.46% |
2022 Q4 | 608.46 Thousand CAD | 3.63% |
2022 Q3 | 587.17 Thousand CAD | -21.97% |
2022 Q2 | 752.49 Thousand CAD | 3.63% |
2021 Q1 | 1.59 Million CAD | 7.18% |
2021 FY | 1.33 Million CAD | -10.38% |
2021 Q2 | 1.6 Million CAD | 0.33% |
2021 Q4 | 1.33 Million CAD | -16.93% |
2021 Q3 | 1.6 Million CAD | 0.33% |
2020 Q2 | 978.33 Thousand CAD | 43.34% |
2020 FY | 1.49 Million CAD | 28.13% |
2020 Q1 | 682.52 Thousand CAD | -41.34% |
2020 Q4 | 1.49 Million CAD | 52.38% |
2020 Q3 | 978.33 Thousand CAD | 0.0% |
2019 Q3 | 1.2 Million CAD | -7.1% |
2019 Q1 | 753.4 Thousand CAD | -30.99% |
2019 Q4 | 1.16 Million CAD | -3.31% |
2019 FY | 1.16 Million CAD | 6.58% |
2019 Q2 | 1.29 Million CAD | 71.93% |
2018 Q4 | 1.09 Million CAD | 159.49% |
2018 FY | 1.09 Million CAD | 165.81% |
2018 Q1 | 418.2 Thousand CAD | 1.83% |
2018 Q2 | 420.7 Thousand CAD | 0.6% |
2018 Q3 | 420.7 Thousand CAD | 0.0% |
2017 Q3 | 352.92 Thousand CAD | -10.81% |
2017 Q2 | 395.7 Thousand CAD | -9.76% |
2017 Q1 | 438.48 Thousand CAD | -25.95% |
2017 FY | 410.7 Thousand CAD | -30.64% |
2017 Q4 | 410.7 Thousand CAD | 16.37% |
2016 Q3 | 633.29 Thousand CAD | -1.18% |
2016 Q1 | 2.21 Million CAD | 0.34% |
2016 Q4 | 592.17 Thousand CAD | -6.49% |
2016 Q2 | 640.84 Thousand CAD | -71.11% |
2016 FY | 592.17 Thousand CAD | -73.21% |
2015 Q2 | 2.04 Million CAD | 11.47% |
2015 FY | 2.21 Million CAD | 20.7% |
2015 Q1 | 1.83 Million CAD | 0.0% |
2015 Q4 | 2.21 Million CAD | -3.85% |
2015 Q3 | 2.29 Million CAD | 12.61% |
2014 Q2 | 996.12 Thousand CAD | 1.48% |
2014 Q4 | 1.83 Million CAD | 2.39% |
2014 Q3 | 1.78 Million CAD | 79.55% |
2014 Q1 | 981.62 Thousand CAD | 1.5% |
2014 FY | 1.83 Million CAD | 89.36% |
2013 Q4 | 967.12 Thousand CAD | 0.0% |
2013 FY | 967.12 Thousand CAD | 0.0% |
2013 Q3 | - CAD | 0.0% |
2013 Q2 | - CAD | 0.0% |
2013 Q1 | - CAD | 0.0% |
2012 Q4 | - CAD | 0.0% |
2012 Q3 | - CAD | 0.0% |
2012 Q2 | - CAD | 0.0% |
2012 Q1 | - CAD | 0.0% |
2012 FY | - CAD | 0.0% |
2011 Q3 | - CAD | 0.0% |
2011 FY | - CAD | 0.0% |
2011 Q1 | - CAD | 0.0% |
2011 Q4 | - CAD | 0.0% |
2011 Q2 | - CAD | 0.0% |
2010 FY | - CAD | 0.0% |
2010 Q1 | - CAD | 0.0% |
2010 Q2 | - CAD | 0.0% |
2010 Q3 | - CAD | 0.0% |
2010 Q4 | - CAD | 0.0% |
2009 FY | - CAD | 0.0% |
2009 Q2 | - CAD | 0.0% |
2009 Q3 | - CAD | 0.0% |
2009 Q1 | - CAD | 0.0% |
2009 Q4 | - CAD | 0.0% |
2008 Q2 | - CAD | 0.0% |
2008 FY | - CAD | 0.0% |
2008 Q4 | - CAD | 0.0% |
2008 Q1 | - CAD | 0.0% |
2008 Q3 | - CAD | 0.0% |
2007 Q1 | - CAD | 0.0% |
2007 Q3 | - CAD | 0.0% |
2007 Q2 | - CAD | 0.0% |
2007 Q4 | - CAD | 0.0% |
2007 FY | - CAD | 0.0% |
2006 Q3 | - CAD | 0.0% |
2006 Q2 | - CAD | 0.0% |
2006 Q4 | - CAD | 0.0% |
2006 FY | - CAD | 0.0% |
2006 Q1 | - CAD | 0.0% |
2005 FY | - CAD | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
BioMark Diagnostics Inc. | 805.93 Thousand CAD | 34.525% |
Izotropic Corporation | 2.05 Million CAD | 74.339% |